$AME

Stanage Nick L purchased $1.0M of AME

Stanage Nick L purchased 4,000 shares of AMETEK INC/ (AME) at $255.85 ($1.02M total) on 2026-08-11.

Original reporting
SEC EDGAR · Stanage Nick L
Published Aug 12, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AME
Neutral
medium confidence
Mentioned
$AME
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMENeutralLow
01

Why it matters

The disclosed fact is the size and price of the director’s purchase, which can slightly influence sentiment but does not change the company’s disclosed outlook.

02

Market read

Traders may note the insider buying as a small positive signal, but it is unlikely to be a standalone catalyst.

03

What to watch

No 10b5-1 plan is cited, but the article also provides no context on prior holdings, motivation, or whether other insiders acted.

Relevance 7/10Novelty 3/10Timing: filed 2026-08-12 after-hours; trade signal is based on 2026-08-11 purchase

Background

This is an SEC Form 4 insider transaction disclosure for AMETEK, reported from an open-market purchase by a director.

Company-level read

Ticker impact

$AMENeutralMedium confidence
Context

Director Stanage Nick L bought 4,000 shares of AMETEK at $255.85 on 2026-08-11, totaling $1.02M, per Form 4.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades.

Evidence & confidence

The filing is primary-source and time-stamped, but it does not include new company fundamentals, guidance, or operational/regulatory developments.

Market effects

No clear sector read-through from a single AMETEK director purchase.

None indicated.

None indicated.

Counterpoint

Insider purchases can be routine, tax- or liquidity-driven, and may not reflect a new view on near-term fundamentals.

Key entities

  • AME

    AMETEK Inc., the issuer of the Form 4 insider transaction.

  • Stanage Nick L

    Director who purchased 4,000 shares on 2026-08-11 at $255.85.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMEHighAI 9/10

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

$AMEHighAI 9/10

AMETEK Raises 2026 Outlook After Earnings Climb 17%

AMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.

$AMEHighAI 9/10

AMETEK (AME) Q2 2026 Earnings Call Transcript

AMETEK (AME) reported Q2 2026 net sales of $2.04B, up 15% year over year, with 10% organic growth. Adjusted EPS was $2.09, up 17%, above guidance of $1.96 to $2.00. Total orders were $2.3B, up 28%, backlog $4.11B. Full-year sales guidance rose about 10% and adjusted EPS to $8.20-$8.30.

$AMEMed

Segment Demand and Strategic Acquisitions Propel Growth

AMETEK (NYSE: AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year over year, beating Wall Street expectations. Non-GAAP EPS was $2.09, 4.8% above consensus. Management cited organic growth, rising orders and backlog of $4.11 billion, and contributions from acquisitions. Full-year guidance was raised, supported by AI, defense, and power grid demand.

$AMEMedAI 8/10

AMETEK, Inc. Q2 2026 Earnings Call Summary

AMETEK reported Q2 2026 momentum driven by multi-year infrastructure build-outs for AI, semiconductors, and power. Organic sales growth accelerated, with a record $4.11B backlog and about 80% expected to ship in 12 months. Core EMG margins rose 290 bps. Full-year 2026 organic sales guidance was raised to mid-to-high single digits; Indicor Instrumentation acquisition of $5B expected to close in H2 with 10% to 12% synergies.

$AMEHigh

AMETEK INC/ (AME): Results of Operations and Financial Condition

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ametek8kexhibit99108042026.htm EX-99.1 Document Exhibit 99.1 AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Aug 4, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30,